AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionRB Capital Management, LLC
Latest Disclosed Ownership14,916 shares
Latest Disclosed Value $ 3,244,129
RB Capital Management, LLC reports 1.24% increase in ownership of 4AB / AbbVie Inc.

On May 14, 2026 - RB Capital Management, LLC filed a 13F-HR form disclosing ownership of 14,916 shares of AbbVie Inc. (BG:4AB) valued at $3,244,129 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 14,733 shares of AbbVie Inc.. This represents a change in shares of 1.24% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 14,916 183 1.24 3,244 -3.62 0.6891
2026-02-03 2025-12-31 13F ABBVIE COM 00287Y109 14,733 104 0.71 3,366 -0.62 0.6687
2025-10-21 2025-09-30 13F ABBVIE COM 00287Y109 14,629 376 2.64 3,387 28.05 0.6991
2025-07-07 2025-06-30 13F ABBVIE COM 00287Y109 14,253 192 1.37 2,646 -10.22 0.5991
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 14,061 192 1.38 2,946 19.56 0.6833
2025-02-18 2024-12-31 13F ABBVIE COM 00287Y109 13,869 -270 -1.91 2,464 -11.75 0.5622
2024-11-18 2024-09-30 13F ABBVIE COM 00287Y109 14,139 26 0.18 2,792 15.37 0.6497
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 14,113 62 0.44 2,421 -5.39 0.5968
2024-05-13 2024-03-31 13F ABBVIE COM 00287Y109 14,051 610 4.54 2,559 22.86 0.6722
2024-02-06 2023-12-31 13F ABBVIE COM 00287Y109 13,441 -273 -1.99 2,083 1.86 0.5965
2023-11-16 2023-09-30 13F ABBVIE COM 00287Y109 13,714 425 3.20 2,044 14.19 0.6370
2023-12-11 2023-06-30 13F/A-1 ABBVIE COM 00287Y109 13,289 474 3.70 1,790 -12.34 0.5386
2023-08-08 2023-06-30 13F ABBVIE COM 00287Y109 13,289 474 1,790 0.4599
2023-05-10 2023-03-31 13F ABBVIE COM 00287Y109 12,815 669 5.51 2,042 4.08 0.6463
2023-01-19 2022-12-31 13F/A-1 ABBVIE COM 00287Y109 12,146 426 3.63 1,963 24.73 0.6932
2023-01-11 2022-12-31 13F ABBVIE COM 00287Y109 12,146 426 2 0.6869
2022-10-24 2022-09-30 13F ABBVIE COM 00287Y109 11,720 1,536 15.08 1,573 0.83 0.6028
2022-07-14 2022-06-30 13F ABBVIE COM 00287Y109 10,184 1,069 11.73 1,560 5.55 0.5814
2022-05-10 2022-03-31 13F/A-1 ABBVIE COM 00287Y109 9,115 273 3.09 1,478 23.48 0.4742
2022-04-11 2022-03-31 13F ABBVIE COM 00287Y109 9,115 273 1,478 0.5161
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 8,842 493 5.90 1,197 32.85 0.3735
2021-11-12 2021-09-30 13F ABBVIE COM 00287Y109 8,349 750 9.87 901 5.26 0.3387
2021-08-06 2021-06-30 13F/A-1 ABBVIE COM 00287Y109 7,599 -30 -0.39 856 3.63 0.3232
2021-08-06 2021-06-30 13F ABBVIE COM 00287Y109 7,599 -30 856 0.2102
2021-05-11 2021-03-31 13F ABBVIE COM 00287Y109 7,629 -898 -10.53 826 -9.63 0.3644
2021-02-04 2020-12-31 13F ABBVIE COM 00287Y109 8,527 2,416 39.54 914 70.20 0.4221
2020-11-12 2020-09-30 13F ABBVIE COM 00287Y109 6,111 -342 -5.30 537 -15.17 0.2524
2020-07-31 2020-06-30 13F ABBVIE COM 00287Y109 6,453 28 0.44 633 31.06 0.3355
2020-05-15 2020-03-31 13F ABBVIE COM 00287Y109 6,425 -137 -2.09 483 -17.01 0.3104
2020-02-11 2019-12-31 13F ABBVIE COM 00287Y109 6,562 -125 -1.87 582 16.87 0.3322
2019-10-10 2019-09-30 13F/A-1 ABBVIE COM 00287Y109 6,687 780 13.20 498 16.08 0.3196
2019-10-10 2019-09-30 13F ABBVIE COM 00287Y109 6,687 780 498
2019-08-07 2019-06-30 13F ABBVIE COM 00287Y109 5,907 196 3.43 429 -6.94 0.3124
2019-05-08 2019-03-31 13F ABBVIE COM 00287Y109 5,711 376 7.05 461 -6.30 0.3759
2019-01-15 2018-12-31 13F ABBVIE COM 00287Y109 5,335 106 2.03 492 -0.61 0.4961
2018-11-13 2018-09-30 13F ABBVIE COM 00287Y109 5,229 -886 -14.49 495 -12.70 0.4392
2018-07-27 2018-06-30 13F ABBVIE COM 00287Y109 6,115 941 18.19 567 15.71 0.4201
2018-04-18 2018-03-31 13F ABBVIE COM 00287Y109 5,174 107 2.11 490 0.00 0.3853
2018-02-02 2017-12-31 13F ABBVIE COM 00287Y109 5,067 128 2.59 490 11.62 0.3490
2017-11-13 2017-09-30 13F ABBVIE COM 00287Y109 4,939 -375 -7.06 439 14.03 0.0058
2017-07-10 2017-06-30 13F ABBVIE COM 00287Y109 5,314 -123 -2.26 385 8.76 0.3322
2017-05-04 2017-03-31 13F ABBVIE COM 00287Y109 5,437 663 13.89 354 18.39 0.3353
2017-02-15 2016-12-31 13F ABBVIE COM 00287Y109 4,774 4,774 299 0.2988
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.